Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling

被引:31
作者
Dastmalchi, Farhad [1 ]
Karachi, Aida [1 ]
Yang, Changlin [1 ]
Azari, Hassan [1 ]
Sayour, Elias Joseph [1 ]
Dechkovskaia, Anjelika [1 ]
Vlasak, Alexander Loren [1 ]
Saia, Megan Ellen [1 ]
Lovaton, Rolando Eladio [2 ]
Mitchell, Duane Anthony [1 ]
Rahman, Maryam [1 ]
机构
[1] Univ Florida, UF Brain Tumor Immunotherapy Program, Preston A Wells Jr Ctr Brain Tumor Therapy, Gainesville, FL 32611 USA
[2] Hosp Cayetano Heredia, Neurosurg Serv, Lima, Peru
关键词
Dendritic cell vaccine; Immunotherapy; Glioblastoma; Cell migration; Sarcosine; CXCR2; GLYCINE TRANSPORTER GLYT1; EXPRESSION; MICE; VACCINATION;
D O I
10.1186/s40425-019-0809-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Dendritic cell (DC) vaccine efficacy is directly related to the efficiency of DC migration to the lymph node after delivery to the patient. We discovered that a naturally occurring metabolite, sarcosine, increases DC migration in human and murine cells resulting in significantly improved anti-tumor efficacy. We hypothesized that sarcosine induced cell migration was due to chemokine signaling. Methods DCs were harvested from the bone marrow of wild type C57BL/6 mice and electroporated with tumor messenger RNA (mRNA). Human DCs were isolated from peripheral blood mononuclear cells (PBMCs). DCs were treated with 20 mM of sarcosine. Antigen specific T cells were isolated from transgenic mice and injected intravenously into tumor bearing mice. DC vaccines were delivered via intradermal injection. In vivo migration was evaluated by flow cytometry and immunofluorescence microscopy. Gene expression in RNA was investigated in DCs via RT-PCR and Nanostring. Results Sarcosine significantly increased human and murine DC migration in vitro. In vivo sarcosine-treated DCs had significantly increased migration to both the lymph nodes and spleens after intradermal delivery in mice. Sarcosine-treated DC vaccines resulted in significantly improved tumor control in a B16F10-OVA tumor flank model and improved survival in an intracranial GL261-gp100 glioma model. Gene expression demonstrated an upregulation of CXCR2, CXCL3 and CXCL1 in sarcosine- treated DCs. Further metabolic analysis demonstrated the up-regulation of cyclooxygenase-1 and Pik3cg. Sarcosine induced migration was abrogated by adding the CXCR2 neutralizing antibody in both human and murine DCs. CXCR2 neutralizing antibody also removed the survival benefit of sarcosine-treated DCs in the tumor models. Conclusion Sarcosine increases the migration of murine and human DCs via the CXC chemokine pathway. This platform can be utilized to improve existing DC vaccine strategies.
引用
收藏
页数:13
相关论文
共 30 条
[1]   Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial [J].
Ardon, Hilko ;
Van Gool, Stefaan W. ;
Verschuere, Tina ;
Maes, Wim ;
Fieuws, Steffen ;
Sciot, Raf ;
Wilms, Guido ;
Demaerel, Philippe ;
Goffin, Jan ;
Van Calenbergh, Frank ;
Menten, Johan ;
Clement, Paul ;
Debiec-Rychter, Maria ;
De Vleeschouwer, Steven .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (11) :2033-2044
[2]   CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1 [J].
Braber, Saskia ;
Overbeek, Saskia A. ;
Koelink, Pim J. ;
Henricks, Paul A. J. ;
Zaman, Guido J. R. ;
Garssen, Johan ;
Kraneveld, Aletta D. ;
Folkerts, Gert .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 668 (03) :443-449
[3]   Polyethylene glycol-modified GM-CSF expands CD11bhighCD11chigh but not CD11blowCD11chigh murine dendritic cells in vivo:: A comparative analysis with Flt3 ligand [J].
Daro, E ;
Pulendran, N ;
Brasel, K ;
Teepe, M ;
Pettit, D ;
Lynch, DH ;
Vremec, D ;
Robb, L ;
Shortman, K ;
McKenna, HJ ;
Maliszewski, CR ;
Maraskovsky, E .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :49-58
[4]  
Farhad D, 2018, DENDRITIC CELL THERA
[5]   Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8 [J].
Feijoó, E ;
Alfaro, C ;
Mazzolini, G ;
Serra, P ;
Peñuelas, I ;
Arina, A ;
Huarte, E ;
Tirapu, I ;
Palencia, B ;
Murillo, O ;
Ruiz, J ;
Sangro, B ;
Richter, JA ;
Prieto, J ;
Melero, I .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (02) :275-281
[6]   Importance of CXC Chemokine Receptor 2 in Alveolar Neutrophil and Exudate Macrophage Recruitment in Response to Pneumococcal Lung Infection [J].
Herbold, Wiebke ;
Maus, Regina ;
Hahn, Ines ;
Ding, Nadine ;
Srivastava, Mrigank ;
Christman, John W. ;
Mack, Matthias ;
Reutershan, Joerg ;
Briles, David E. ;
Paton, James C. ;
Winter, Christine ;
Welte, Tobias ;
Maus, Ulrich A. .
INFECTION AND IMMUNITY, 2010, 78 (06) :2620-2630
[7]   Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage [J].
Howard, Alison ;
Tahir, Imran ;
Javed, Sajid ;
Waring, Sarah M. ;
Ford, Dianne ;
Hirst, Barry H. .
JOURNAL OF PHYSIOLOGY-LONDON, 2010, 588 (06) :995-1009
[8]   The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics [J].
Johnson, Louise A. ;
Jackson, David G. .
JOURNAL OF CELL SCIENCE, 2013, 126 (22) :5259-5270
[9]   Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. [J].
Kantoff, Philip W. ;
Higano, Celestia S. ;
Shore, Neal D. ;
Berger, E. Roy ;
Small, Eric J. ;
Penson, David F. ;
Redfern, Charles H. ;
Ferrari, Anna C. ;
Dreicer, Robert ;
Sims, Robert B. ;
Xu, Yi ;
Frohlich, Mark W. ;
Schellhammer, Paul F. ;
Ahmed, T. ;
Amin, A. ;
Arseneau, J. ;
Barth, N. ;
Bernstein, G. ;
Bracken, B. ;
Burch, P. ;
Caggiano, V. ;
Chin, J. ;
Chodak, G. ;
Chu, F. ;
Corman, J. ;
Curti, B. ;
Dawson, N. ;
Deeken, J. F. ;
Dubernet, T. ;
Fishman, M. ;
Flanigan, R. ;
Gailani, F. ;
Garbo, L. ;
Gardner, T. ;
Gelmann, E. ;
George, D. ;
Godfrey, T. ;
Gomella, L. ;
Guerra, M. ;
Hall, S. ;
Hanson, J. ;
Israeli, R. ;
Jancis, E. ;
Jewett, M. A. S. ;
Kassabian, V. ;
Katz, J. ;
Klotz, L. ;
Koeneman, K. ;
Koh, H. ;
Kratzke, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05) :411-422
[10]   CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses [J].
Kielian, T ;
Barry, B ;
Hickey, WF .
JOURNAL OF IMMUNOLOGY, 2001, 166 (07) :4634-4643